References
- Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, Zhu AX, Murad MH, Marrero JA. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358–380. doi:https://doi.org/10.1002/hep.29086
- Raghunath A, Sundarraj K, Arfuso F, Sethi G, Perumal E. Dysregulation of Nrf2 in hepatocellular carcinoma: role in cancer progression and chemoresistance. Cancers. 2018;10(12):481. doi:https://doi.org/10.3390/cancers10120481
- Baskar R, Lee KA, Yeo R, Yeoh KW. Cancer and radiation therapy: current advances and future directions. Int J Med Sci. 2012;9(3):193–199. doi:https://doi.org/10.7150/ijms.3635
- Rinninella E, Cerrito L, Spinelli I, Cintoni M, Mele MC, Pompili M, Gasbarrini A. Chemotherapy for hepatocellular carcinoma: current evidence and future perspectives. J Clin Transl Hepatol. 2017;5(3):235–248. doi:https://doi.org/10.14218/JCTH.2017.00002
- Moeini A, Cornella H, Villanueva A. Emerging signaling pathways in hepatocellular carcinoma. Liver Cancer. 2012;1(2):83–93. doi:https://doi.org/10.1159/000342405
- Dhanasekaran R, Bandoh S, Roberts LR. Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances. F1000Res. 2016;5:879. doi:https://doi.org/10.12688/f1000research.6946.1
- Maycotte P, Thorburn A. Autophagy and cancer therapy. Cancer Biol Ther. 2011;11(2):127–137. doi:https://doi.org/10.4161/cbt.11.2.14627
- Xie Z, Klionsky DJ. Autophagosome formation: core machinery and adaptations. Nat Cell Biol. 2007;9(10):1102–1109. doi:https://doi.org/10.1038/ncb1007-1102
- Pattingre S, Espert L, Biard-Piechaczyk M, Codogno P. Regulation of macroautophagy by mTOR and Beclin 1 complexes. Biochimie. 2008;90(2):313–323. doi:https://doi.org/10.1016/j.biochi.2007.08.014
- Cantley LC. The phosphoinositide 3-kinase pathway. Science. 2002;296(5573):1655–1657. doi:https://doi.org/10.1126/science.296.5573.1655
- He C, Klionsky DJ. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet. 2009;43:67–93. doi:https://doi.org/10.1146/annurev-genet-102808-114910
- Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol. 2012;13(4):251–262. doi:https://doi.org/10.1038/nrm3311
- Mihaylova MM, Shaw RJ. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol. 2011;13(9):1016–1023. doi:https://doi.org/10.1038/ncb2329
- Samari HR, Seglen PO. Inhibition of hepatocytic autophagy by adenosine, aminoimidazole-4-carboxamide riboside, and N6-mercaptopurine riboside. Evidence for involvement of amp-activated protein kinase. J Biol Chem. 1998;273(37):23758–23763. doi:https://doi.org/10.1074/jbc.273.37.23758
- Sundarraj K, Raghunath A, Perumal E. A review on the chemotherapeutic potential of fisetin: in vitro evidences. Biomed Pharmacother. 2018;97:928–940. doi:https://doi.org/10.1016/j.biopha.2017.10.164
- Abotaleb M, Samuel S, Varghese E, Varghese S, Kubatka P, Liskova A, Büsselberg D. Flavonoids in cancer and apoptosis. Cancer (Basel). 2018;11(1):28. doi:https://doi.org/10.3390/cancers11010028
- Khan N, Syed DN, Ahmad N, Mukhtar H. Fisetin: a dietary antioxidant for health promotion. Antioxid Redox Signal. 2013;19(2):151–162. doi:https://doi.org/10.1089/ars.2012.4901
- Lee SE, Jeong SI, Yang H, Park C-S, Jin Y-H, Park YS. Fisetin induces Nrf2-mediated HO-1 expression through PKC-δ and p38 in human umbilical vein endothelial cells. J Cell Biochem. 2011;112(9):2352–2360. doi:https://doi.org/10.1002/jcb.23158
- Park B-S, Choi N-E, Lee JH, Kang H-M, Yu S-B, Kim H-J, Kang H-K, Kim I-R. Crosstalk between fisetin-induced apoptosis and autophagy in human oral squamous cell carcinoma. J Cancer. 2019;10(1):138–146. doi:https://doi.org/10.7150/jca.28500
- Yang PM, Tseng HH, Peng CW, Chen WS, Chiu SJ. Dietary flavonoid fisetin targets caspase-3-deficient human breast cancer MCF-7 cells by induction of nduction of caspase-7-associated apoptosis and inhibition of autophagy. Int J Oncol. 2012;40(2):469–478. doi:https://doi.org/10.3892/ijo.2011.1203
- Sundarraj K, Raghunath A, Panneerselvam L, Perumal E. Fisetin, a phytopolyphenol, targets apoptotic and necroptotic cell death in HepG2 cells. Biofactors. 2020;46(1):118–135. doi:https://doi.org/10.1002/biof.1577
- Kovsan J, Blüher M, Tarnovscki T, Klöting N, Kirshtein B, Madar L, Shai I, Golan R, Harman-Boehm I, Schön MR, et al. Altered autophagy in human adipose tissues in obesity. J Clin Endocrinol Metab. 2011;96(2):E268–E277. doi:https://doi.org/10.1210/jc.2010-1681
- Wang W-S, Li W-J, Wang Y-W, Wang L-Y, Mi Y-B, Lu J-W, Lu Y, Zhang C-Y, Sun K. Involvement of serum amyloid A1 in the rupture of fetal membranes through induction of collagen I degradation. Clin Sci (Lond). 2019;133(3):515–530. doi:https://doi.org/10.1042/CS20180950
- Oh JY, Choi GE, Lee HJ, Jung YH, Ko SH, Chae CW, Kim JS, Kim SY, Lim JR, Lee C-K, et al. High glucose-induced reactive oxygen species stimulates human mesenchymal stem cell migration through snail and EZH2-dependent E-cadherin repression. Cell Physiol Biochem. 2018;46(5):1749–1767. doi:https://doi.org/10.1159/000489360
- Treeck O, Wackwitz B, Haus U, Ortmann O. Effects of a combined treatment with mTOR inhibitor RAD001 and tamoxifen in vitro on growth and apoptosis of human cancer cells. Gynecol Oncol. 2006;102(2):292–299. doi:https://doi.org/10.1016/j.ygyno.2005.12.019
- Wu ZZ, Zhang JJ, Gao CC, Zhao M, Liu SY. Expression of autophagy related genes mTOR, Beclin-1, LC3 and p62 in the peripheral blood mononuclear cells of systemic lupus erythematosus. Am J Clin Exp Immunol. 2017;6:1–8.
- Moriwaki K, Bertin J, Gough PJ, Orlowski GM, Chan FK. Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death. Cell Death Dis. 2015;6:e1636. doi:https://doi.org/10.1038/cddis.2015.16
- Chen N, Karantza-Wadsworth V. Role and regulation of autophagy in cancer. Biochim Biophys Acta. 2009;1793(9):1516–1523. doi:https://doi.org/10.1016/j.bbamcr.2008.12.013
- Dyshlovoy SA, Menchinskaya ES, Venz S, Rast S, Amann K, Hauschild J, Otte K, Kalinin VI, Silchenko AS, Avilov SA, et al. The marine triterpene glycoside frondoside A exhibits activity in vitro and in vivo in prostate cancer. Int J Cancer. 2016;138(10):2450–2465. doi:https://doi.org/10.1002/ijc.29977
- Shimizu S, Takehara T, Hikita H, Kodama T, Tsunematsu H, Miyagi T, Hosui A, Ishida H, Tatsumi T, Kanto T, et al. Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma. Int J Cancer. 2012;131(3):548–557. doi:https://doi.org/10.1002/ijc.26374
- Adhami VM, Syed DN, Khan N, Mukhtar H. Dietary flavonoid fisetin: a novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management. Biochem Pharmacol. 2012;84(10):1277–1281. doi:https://doi.org/10.1016/j.bcp.2012.07.012
- Ishige K, Schubert D, Sagara Y. Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic Biol Med. 2001;30(4):433–446. doi:https://doi.org/10.1016/s0891-5849(00)00498-6
- Zbarsky V, Datla KP, Parkar S, Rai DK, Aruoma OI, Dexter DT. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radic Res. 2005;39(10):1119–1125. doi:https://doi.org/10.1080/10715760500233113
- Kim JA, Lee S, Kim D-E, Kim M, Kwon B-M, Han DC. Fisetin a dietary flavonoid, induces apoptosis of cancer cells by inhibiting HSF1 activity through blocking its binding to the hsp70 promoter. Carcinogenesis. 2015;36(6):696–706. doi:https://doi.org/10.1093/carcin/bgv045
- Chen Y, Wu Q, Song L, He T, Li Y, Li L, Su W, Liu L, Qian Z, Gong C, et al. Polymeric micelles encapsulating fisetin improve the therapeutic effect in colon cancer. ACS Appl Mater Interfaces. 2015;7(1):534–542. doi:https://doi.org/10.1021/am5066893
- Gordon PB, Holen I, Seglen PO. Protection by naringin and some other flavonoids of hepatocytic autophagy and endocytosis against inhibition by okadaic acid. J Biol Chem. 1995;270(11):5830–5838. doi:https://doi.org/10.1074/jbc.270.11.5830
- Ryter SW, Cloonan SM, Choi AM. Autophagy: a critical regulator of cellular metabolism and homeostasis. Mol Cells. 2013;36(1):7–16. doi:https://doi.org/10.1007/s10059-013-0140-8
- Klose J, Stankov MV, Kleine M, Ramackers W, Panayotova-Dimitrova D, Jäger MD, Klempnauer J, Winkler M, Bektas H, Behrens GMN, et al. Inhibition of autophagic flux by salinomycin results in anti-cancer effect in hepatocellular carcinoma cells. PLoS One. 2014;9(5):e95970. doi:https://doi.org/10.1371/journal.pone.0095970
- Yue W, Hamaï A, Tonelli G, Bauvy C, Nicolas V, Tharinger H, Codogno P, Mehrpour M. Inhibition of the autophagic flux by salinomycin in breast cancer stem-like/progenitor cells interferes with their maintenance. Autophagy. 2013;9(5):714–729. doi:https://doi.org/10.4161/auto.23997
- Zhang W, Dong YZ, Du X, Peng XN, Shen QM. MiRNA-153-3p promotes gefitinib-sensitivity in non-small cell lung cancer by inhibiting ATG5 expression and autophagy. Eur Rev Med Pharmacol Sci. 2019;23(6):2444–2452. doi:https://doi.org/10.26355/eurrev_201903_17391
- Xu Z, Han X, Ou D, Liu T, Li Z, Jiang G, Liu J, Zhang J. Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy. Appl Microbiol Biotechnol. 2020;104(2):575–587. doi:https://doi.org/10.1007/s00253-019-10257-8
- Yun CW, Lee SH. The roles of autophagy in cancer. IJMS. 2018;19(11):3466. doi:https://doi.org/10.3390/ijms19113466
- LoPiccolo J, Blumenthal GM, Bernstein WB, Dennis PA. Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations. Drug Resist Updat. 2008;11(1–2):32–50. doi:https://doi.org/10.1016/j.drup.2007.11.003
- Khan N, Afaq F, Khusro FH, Mustafa Adhami V, Suh Y, Mukhtar H. Dual inhibition of phosphatidylinositol 3-kinase/Akt and mammalian target of rapamycin signaling in human nonsmall cell lung cancer cells by a dietary flavonoid fisetin. Int J Cancer. 2012;130(7):1695–1705. doi:https://doi.org/10.1002/ijc.26178
- Gurusamy N, Lekli I, Mukherjee S, Ray D, Ahsan MK, Gherghiceanu M, Popescu LM, Das DK. Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway. Cardiovasc Res. 2010;86(1):103–112. doi:https://doi.org/10.1093/cvr/cvp384
- Suh Y, Afaq F, Khan N, Johnson JJ, Khusro FH, Mukhtar H. Fisetin induces autophagic cell death through suppression of mTOR signaling pathway in prostate cancer cells. Carcinogenesis. 2010;31(8):1424–1433. doi:https://doi.org/10.1093/carcin/bgq115
- Peltier J, O'Neill A, Schaffer DV. PI3K/Akt and CREB regulate adult neural hippocampal progenitor proliferation and differentiation. Dev Neurobiol. 2007;67(10):1348–1361. doi:https://doi.org/10.1002/dneu.20506
- Hong Z-F, Zhao W-X, Yin Z-Y, Xie C-R, Xu Y-P, Chi X-Q, Zhang S, Wang X-M. Capsaicin enhances the drug sensitivity of cholangiocarcinoma through the inhibition of chemotherapeutic-induced autophagy. PLoS One. 2015;10(5):e0121538. doi:https://doi.org/10.1371/journal.pone.0121538
- Toton E, Lisiak N, Sawicka P, Rybczynska M. Beclin-1 and its role as a target for anticancer therapy. J Physiol Pharmacol. 2014;65(4):459–467.
- Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell. 2010;140(3):313–326. doi:https://doi.org/10.1016/j.cell.2010.01.028
- Gong C, Bauvy C, Tonelli G, Yue W, Deloménie C, Nicolas V, Zhu Y, Domergue V, Marin-Esteban V, Tharinger H, et al. Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like/progenitor cells. Oncogene. 2013;32(18):2261–2272. doi:https://doi.org/10.1038/onc.2012.252
- Tanida I, Ueno T, Kominami E. LC3 and autophagy. Methods Mol Biol. 2008;445:77–88. doi:https://doi.org/10.1007/978-1-59745-157-4_4
- Gozuacik D, Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene. 2004;23(16):2891–2906. doi:https://doi.org/10.1038/sj.onc.1207521
- Fu X-T, Song K, Zhou J, Shi Y-H, Liu W-R, Shi G-M, Gao Q, Wang X-Y, Ding Z-B, Fan J, et al. Tumor-associated macrophages modulate resistance to oxaliplatin via inducing autophagy in hepatocellular carcinoma. Cancer Cell Int. 2019;19:71. doi:https://doi.org/10.1186/s12935-019-0771-8
- Kondo Y, Kanzawa T, Sawaya R, Kondo S. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer. 2005;5(9):726–734. doi:https://doi.org/10.1038/nrc1692
- Xie B-S, Zhao H-C, Yao S-K, Zhuo D-X, Jin B, Lv D-C, Wu C-L, Ma D-L, Gao C, Shu X-M, et al. Autophagy inhibition enhances etoposide-induced cell death in human hepatoma G2 cells. Int J Mol Med. 2011;27(4):599–606. doi:https://doi.org/10.3892/ijmm.2011.607
- Chen J, Zhang L, Zhou H, Wang W, Luo Y, Yang H, Yi H. Inhibition of autophagy promotes cisplatin-induced apoptotic cell death through Atg5 and Beclin 1 in A549 human lung cancer cells. Mol Med Rep. 2018;17(5):6859–6865. doi:https://doi.org/10.3892/mmr.2018.8686
- Li X, Zhou Y, Li Y, Yang L, Ma Y, Peng X, Yang S, Liu J, Li H. Autophagy: a novel mechanism of chemoresistance in cancers. Biomed Pharmacother. 2019;119:109415. doi:https://doi.org/10.1016/j.biopha.2019.109415
- Bhardwaj M, Cho HJ, Paul S, Jakhar R, Khan I, Lee S-J, Kim B-Y, Krishnan M, Khaket TP, Lee HG, et al. Vitexin induces apoptosis by suppressing autophagy in multi-drug resistant colorectal cancer cells. Oncotarget. 2018;9(3):3278–3291. doi:https://doi.org/10.18632/oncotarget.22890
- Boya P, González-Polo R-A, Casares N, Perfettini J-L, Dessen P, Larochette N, Métivier D, Meley D, Souquere S, Yoshimori T, et al. Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol. 2005;25(3):1025–1040. doi:https://doi.org/10.1128/MCB.25.3.1025-1040.2005
- He PX, Che YS, He QJ, Chen Y, Ding J. G226, a novel epipolythiodioxopiperazine derivative, induces autophagy and caspase-dependent apoptosis in human breast cancer cells in vitro. Acta Pharmacol Sin. 2014;35(8):1055–1064. doi:https://doi.org/10.1038/aps.2014.47
- Li L, Yu S, Zang C. Low Necroptosis process predicts poor treatment outcome of human papillomavirus positive cervical cancers by decreasing tumor-associated macrophages M1 polarization. Gynecol Obstet Invest. 2018;83(3):259–267. doi:https://doi.org/10.1159/000487434
- Inoki K, Kim J, Guan KL. AMPK and mTOR in cellular energy homeostasis and drug targets. Annu Rev Pharmacol Toxicol. 2012;52:381–400. doi:https://doi.org/10.1146/annurev-pharmtox-010611-134537
- Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13(2):132–141. doi:https://doi.org/10.1038/ncb2152
- Kou B, Liu W, Xu X, Yang Y, Yi Q, Guo F, Li J, Zhou J, Kou Q. Autophagy induction enhances tetrandrine-induced apoptosis via the AMPK/mTOR pathway in human bladder cancer cells. Oncol Rep. 2017;38(5):3137–3143. doi:https://doi.org/10.3892/or.2017.5988
- Wang G-Y, Bi Y-G, Liu X-D, Han J-F, Wei M, Zhang Q-Y. Upregulation of connexin 43 and apoptosis-associated protein expression by high glucose in H9c2 cells was improved by resveratrol via the autophagy signaling pathway. Mol Med Rep. 2017;16(3):3262–3268. doi:https://doi.org/10.3892/mmr.2017.6953
- Mariño G, Pietrocola F, Eisenberg T, Kong Y, Malik SA, Andryushkova A, Schroeder S, Pendl T, Harger A, Niso-Santano M, et al. Regulation of autophagy by cytosolic acetyl-coenzyme A. Mol Cell. 2014;53(5):710–725. doi:https://doi.org/10.1016/j.molcel.2014.01.016
- Kanamori H, Takemura G, Goto K, Tsujimoto A, Ogino A, Takeyama T, Kawaguchi T, Watanabe T, Morishita K, Kawasaki M, et al. Resveratrol reverses remodeling in hearts with large, old myocardial infarctions through enhanced autophagy-activating AMP kinase pathway. Am J Pathol. 2013;182(3):701–713. doi:https://doi.org/10.1016/j.ajpath.2012.11.009
- Tang AH, Rando TA. Induction of autophagy supports the bioenergetic demands of quiescent muscle stem cell activation. Embo J. 2014;33(23):2782–2797. doi:https://doi.org/10.15252/embj.201488278
- Katayama M, Kawaguchi T, Berger MS, Pieper RO. DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells. Cell Death Differ. 2007;14(3):548–558. doi:https://doi.org/10.1038/sj.cdd.4402030
- van Vugt MA, Bràs A, Medema RH. Restarting the cell cycle when the checkpoint comes to a halt. Cancer Res. 2005;65(16):7037–7040. doi:https://doi.org/10.1158/0008-5472.CAN-05-1054